ERBB2 and nonpapillary renal cell carcinoma: Notably, the expression levels BNIP3, CCND1, ERBB2, and PECAM1 were downregulated from stage I to stage IV in ccRCC, while expression of CEBPB, TIMP1, and UBE2C were elevated in higher stage.